Patent Foramen Ovale Closure with the AMPLATZER PFO OCCLUDER in Patients with Recurrent Cryprogenic Stroke Due to Presumed Paradoxical Embolism through a Patent Foramen Ovale Who Have Failed Conventional Drug Therapy (PFO ACCESS Registry)

General Information

Age Group

Adults

Status

Active

Protocol Number

N/A

Offered At

Inova Schar Heart and Vascular
3300 Gallows Rd.
Falls Church, VA  22042
Principal Investigator

James Thompson, MD

Eligibility Information

  • Patients ≥18 years old
  • Patients with a PFO who have already experienced at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale
  • Patients who have failed conventional drug therapy